CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

A breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

Bladder cancer can be a silent killer, often presenting few symptoms in its early stages. Learn about the disease, its early symptoms, and more.

In the neoadjuvant and adjuvant phases of arm C, pembrolizumab will be administered on day 1 and enfortumab vedotin will be administered on days 1 and 8 of each cycle. Enrollment is complete for arm A ...

A Bridgeport resident says the CT DOC's failure to provide timely treatment led to 28 rounds of chemotherapy and the removal ...

Additionally, multivariable analyses demonstrated that detectable ctDNA before radical cystectomy was associated with a higher risk of nodal disease (OR 5.4, 95% CI 1.9-18.2; p = 0.003) and locally ...

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

Sam S. Chang MD, MBA, discusses the findings for mitomycin in for low-grade intermediate-risk nonmuscle-invasive bladder ...

The new data comes shortly after Imfinzi was approved as a peri-operative treatment for muscle-invasive bladder cancer (MIBC), based on the results of the NIAGARA trial, ...

Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, ...